Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.11% Nasdaq Down0.17%

Raptor Pharmaceuticals Corp. (RPTP)

-NasdaqGM

7.93 Up 0.10(1.28%) 1:19PM EDT - Nasdaq Real Time Price

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingNov 29, 2012Aug 30, 2012May 30, 2012Feb 28, 2012
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development6,785  6,436  6,020  3,972  
Selling General and Administrative6,365  5,830  4,105  2,453  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (13,150) (12,265) (10,124) (6,424)
Income from Continuing Operations
Total Other Income/Expenses Net(249)(3,000)12,173  (7,568)
Earnings Before Interest And Taxes(13,399)(15,266)2,049  (13,992)
Interest Expense -  1  1  (0)
Income Before Tax(13,399)(15,267)2,048  (13,992)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(13,399)(15,267)2,048  (13,992)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (13,399) (10,222) (2,997) (13,992)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (13,399) (10,222) (2,997) (13,992)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.